Article · 4 Apr 2025
Review articlePublished 18 Mar 2021
Fingolimod-An Overview
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fingolimod (FTY720) is a sphingosine-1-phosphate-receptor modulator that Is administered orally, which is currently being evaluated for the multiple sclerosis treatment.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2022
Leishmaniasis in a Patient with Fingolimod-Treated Multiple Sclerosis: Infectious Challenges of Disease Modifying Therapies
Commentary · 19 Feb 2021
Impact of fingolimod on multiple sclerosis
Short communication · 18 Feb 2021
Fingolimod and its Treatment in Multiple Sclerosis
Editorial · 2021
Mild COVID-19 Infection in a Patient with Multiple Sclerosis, while Taking Fingolimod: A Case Report
More from this journal
The newest in Journal of Multiple Sclerosis.
Article · 7 Apr 2026
A Link between Smoking and Age at Onset in Multiple Sclerosis
Article · 12 Feb 2026
Demyelination: Understanding the Disruption of Nerve Function
Article · 12 Feb 2026
Brain Tumors: Insights into Diagnosis, Management, and Future Perspectives
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Multiple Sclerosis
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “John”

